Collaborative Clinical Trials in Drug Abuse (R01)

The summary for the Collaborative Clinical Trials in Drug Abuse (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative Clinical Trials in Drug Abuse (R01): -This Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse, National Institutes of Health, is a reissuance of PAR-04-073, Collaborative Clinical Trials in Drug Abuse, published in the NIH Guide for Contracts and Grants, March 9, 2004 at This announcement provides guidelines for the development, review, and funding of Collaborative Clinical Trials in Drug Abuse (CCTDA) through the solicitation of Research Project Grant (R01) applications from institutions/organizations that propose to carry out clinical trials using a common protocol at collaborating sites. One of the sites should be the coordinating site for the trial. Each site must submit a separate R01 application. Although a foreign institution may be a participating site, the coordinating site must be a domestic institution. -Purpose. The National Institute on Drug Abuse (NIDA) seeks to increase the collaboration of investigators at different sites in order to address critical issues in the treatment of substance-related disorders that require sample sizes greater than a single site can reasonably attain. The expectation for the collaborative effort is that there will be implementation of common clinical trials across different sites in order to study patient outcomes, patient factors, provider factors, setting characteristics, interactions of these, or other effects where pooled samples are appropriate and necessary for the hypotheses under consideration. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism.
Federal Grant Title: Collaborative Clinical Trials in Drug Abuse (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-07-232
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Feb 23, 2007
Creation Date: Feb 23, 2007
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Private institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Independent school districts County governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Tri...
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clin...
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Cl...
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance ...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) is not endorsed by, or affiliated with, any government agency. Copyright ©2019